| 120.6 -5.92 (-4.68%) | 07-30 16:00 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term |   |
|||
| Targets | 6-month : | 154.17 | 1-year : | 180.07 |
| Resists | First : | 132 | Second : | 154.17 |
| Pivot price | 117.27 |
|||
| Supports | First : | 113.94 |
Second : | 102.79 |
| MAs | MA(5) : | 123.21 |
MA(20) : | 118.19 |
| MA(100) : | 98.9 |
MA(250) : | 98.36 |
|
| MACD | MACD : | 4.3 |
Signal : | 4 |
| %K %D | K(14,3) : | 73.3 |
D(3) : | 74.7 |
| RSI | RSI(14): 56 |
|||
| 52-week | High : | 132 | Low : | 65.11 |
Price has closed below its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.[ CURE ] has closed below upper band by 34.1%. Bollinger Bands are 16.4% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 121.6 - 122.26 | 122.26 - 122.81 |
| Low: | 115.32 - 116.14 | 116.14 - 116.82 |
| Close: | 119.33 - 120.62 | 120.62 - 121.68 |
The Direxion Daily Healthcare Bull 3X Shares aims to achieve daily financial outcomes that are three times the performance of the Health Care Select Sector Index, prior to accounting for its fees and operational costs. However, there is no guarantee that the fund will successfully meet its stated investment objectives.
Tue, 14 Jul 2026
CURE ETF Profile: Dividends, Returns (AMEX:CURE) - TradingView
Tue, 12 May 2026
U.S. ETF Express | Direxion Daily Semiconductor Bear 3x Shares ETF Was the Top Gainer, Rising 9.15% - Moomoo
Wed, 08 Apr 2026
CURE: Pullback In Healthcare Stocks Presents A Buying Opportunity (NYSEARCA:CURE) - Seeking Alpha
Wed, 08 Apr 2026
Healthcare ETF CURE dips early 2026 as investors take profits, but long-term growth potential remains strong. - Pluang
Tue, 03 Feb 2026
Which Sector Topped the Leaderboard for January Returns? - ETF Trends
Sun, 01 Feb 2026
CURE: Benefits And Caveats Of The Leveraged Healthcare ETF (NYSEARCA:CURE) - Seeking Alpha
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Neutral |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Neutral |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
|
Exchange:
AMEX
|
|
|
Sector:
Financial Services
|
|
|
Industry:
Asset Management - Leveraged
|
|
| Shares Out | 0 (M) |
| Shares Float | 0 (M) |
| Held by Insiders | 0 (%) |
| Held by Institutions | 0 (%) |
| Shares Short | 0 (K) |
| Shares Short P.Month | 0 (K) |
| EPS | 0 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 0 |
| Profit Margin | 0 % |
| Operating Margin | 0 % |
| Return on Assets (ttm) | 0 % |
| Return on Equity (ttm) | 0 % |
| Qtrly Rev. Growth | 0 % |
| Gross Profit (p.s.) | 0 |
| Sales Per Share | 0 |
| EBITDA (p.s.) | 0 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | 0 (M) |
| Levered Free Cash Flow | 0 (M) |
| PE Ratio | 0 |
| PEG Ratio | 0 |
| Price to Book value | 0 |
| Price to Sales | 0 |
| Price to Cash Flow | 0 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|